Addition of Metabolomics to the Omics Spectrum for Cancer Biomarker Development– Demonstration With the KrasG12D Mouse Model for Pancreatic Carcinoma

BMC Genomics - United Kingdom
doi 10.1186/1471-2164-15-s2-o4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Omics Dashboard for Metabolomics Data

2017English

A Metabolomics-Based Biomarker Signature Discriminates Pancreatic Cancer From Chronic Pancreatitis

Gut
Gastroenterology
2017English

Serum Metabolomics as a Novel Diagnostic Approach for Pancreatic Cancer

Metabolomics
BiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2010English

No Functional Role for microRNA-342 in a Mouse Model of Pancreatic Acinar Carcinoma

Frontiers in Oncology
Cancer ResearchOncology
2017English

Delayed Progression of Pancreatic Intraepithelial Neoplasia in a Conditional KrasG12D Mouse Model by a Selective Cyclooxygenase-2 Inhibitor

Cancer Research
Cancer ResearchOncology
2007English

Metabolomics a Novel Biomarker in Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2015English

Genetically Engineered Mouse Models of Pancreatic Cancer: The KPC Model (LSL-KrasG12D/+;LSL-Trp53R172H/+;Pdx-1-Cre), Its Variants, and Their Application in Immuno-Oncology Drug Discovery

Current Protocols in Pharmacology
MedicinePharmacology
2016English

Trans-Omics Biomarker Model Improves Prognostic Prediction Accuracy for Early-Stage Lung Adenocarcinoma

Aging
AgingCell Biology
2019English

Pilot Study of Blood Biomarker Candidates for Detection of Pancreatic Cancer

Pancreas
Internal MedicineEndocrinologyHepatologyMetabolismDiabetes
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy